换一批
换一批Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.
第一作者：
Michael A,Morse
第一单位：
Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Box 3233, Durham, NC 27710, USA. morse004@mc.duke.edu
作者：
主题词
成年人(Adult);抗体生成(Antibody Formation);抗原, 肿瘤(Antigens, Neoplasm);乳腺肿瘤(Breast Neoplasms);CD4阳性T淋巴细胞(CD4-Positive T-Lymphocytes);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);癌症疫苗(Cancer Vaccines);置信区间(Confidence Intervals);无病生存(Disease-Free Survival);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);人类(Humans);超敏反应, 迟发型(Hypersensitivity, Delayed);干扰素γ(Interferon-gamma);细胞内间隙(Intracellular Space);Kaplan-Meiers评估(Kaplan-Meier Estimate);中年人(Middle Aged);蛋白质结构, 三级(Protein Structure, Tertiary);T淋巴细胞(T-Lymphocytes);时间因素(Time Factors);接种(Vaccination)
DOI
10.1186/1479-5876-5-42
PMID
17822557
发布时间
2018-11-13
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
